Intersect ENT to acquire Fiagon's Medical Technologies for $71m.

Intersect ENT, a company transforming care for patients with ear, nose and throat conditions to acquire Medical Technologies business of Fiagon, a surgical navigation solutions, for $71m. “We are excited to join the team at Intersect ENT, an established leader with an advanced therapeutic platform in the large and attractive global ENT market. The combination of Intersect ENT’s compelling product offerings coupled with its deep commercial leadership expertise and impressive sales force offers a unique opportunity for us to jointly leverage our core innovation and commercialization competencies. We look forward to working with the Intersect ENT team to expand market penetration of our instruments and tools globally," Kai Desinger, Fiagon President and CEO.